MARY E. SCHMIDT, MD, MPH, FIDSA

EDUCATION

Doctor of Medicine
The Medical College of Pennsylvania/Drexel University, Philadelphia, PA
1984
Master of Public Health
John’s Hopkins University, Baltimore, MD
2013
Bachelor of Science, Biology, and Chemistry
Elizabethtown College, Elizabethtown, PA
1979
Hospital Epidemiology Training Course
AHA, CDC, SHEA – Sponsors, Chicago IL
1991

MEDICAL FELLOWSHIP

Infectious Diseases
Washington Hospital Center/ Veteran’s Administration Hospital/ George Washington University Medical Center/ Children’s National Medical Center, Washington, D.C.
1989 – 1992

MEDICAL RESIDENCY

Combined Internal Medicine/Pediatrics
Albany Medical Center, Albany, NY
1984 – 1988

MEDICAL LICENSES

State of Virginia (Active)
State of Colorado (Active)

CLINICAL & PROFESSIONAL EXPERIENCE

Schmidt & Libby Health Advisory Group, LLC.
President & Chief Operating Officer

  • Advises businesses and healthcare startup companies on best practices to get buy-in from the public and healthcare institutions
  • Advises businesses and consumers on best practices in the area of infectious diseases
  • Media presence promoting best practices for infectious diseases
  • Board Member, Hememics Biotechnologies Inc.
2014 – Present
INOVA Fairfax Medical Campus, Falls Church, VA
Research and Teaching, Department of Medicine (2015 – Present)      

  • Infectious disease lecture to medical student
  • Public health-related research on national databases and INOVA projects

Chief of Staff, Medical Staff President, & Medical Executive Committee Chair (2011 – 2013)

  • Monitored and created new policies and procedures pertaining to quality, safety, and citizenship of 2,400 physicians
  • Chaired the 950-bed hospital’s only medical policy committee. Members included all medical department chairs, all chief administrators, and nine members-at-large.
2011 – Present
Partner, Infectious Disease Physicians, Inc., Annandale, VA 2008 – 2014
Partner, Infectious Disease Consultants, LLC., Fairfax, VA

  • Responsible for ensuring HIPAA and government compliant procedures were in place
1996 – 2008
Physician, Infectious Disease Physicians, Annandale, VA                                  1992 – 1996
Physician, Emergency Medical Associates, Bethesda, MD 1988 – 1989

ACADEMIC APPOINTMENTS

Virginia Commonwealth University, INOVA Campus, Falls Church, VA
Associate Clinical Professor, Department of Clinical Medicine
2003 – Present
John’s Hopkins University, Baltimore, MD
Adjunct Associate Professor, Bloomberg School of Public Health
2015 – Present
George Washington University, Washington, D.C.
Associate Clinical Professor of Medicine, School of Medicine and Health Sciences
2009 – 2018
University of Virginia, Charlottesville, VA
Assistant Professor of Clinical Medicine
1996 – 2003
Georgetown University, Washington, D.C.
Assistant Professor of Clinical Medicine
1995 – 1997
George Washington University, Washington, D.C.
Instructor of Clinical Medicine, School of Medicine
 1989 – 1990
Albany Medical College, Albany, NY
Instructor of Medicine and Pediatrics
 1985 – 1988

HOSPITAL COMMITTEES

Member, Infectious Diseases Section 1992 – Present
Member, Epic Roll Out Oversight Committee, INOVA Health System 2012 – 2014
Member, INOVA Health System Healthcare Services Board 2011 – 2014
Director, Transplant Infectious Diseases, INOVA Fairfax Hospital  2010 – 2014
Member, INOVA Kidney Transplant Collaborative Practice Committee, INOVA Fairfax Hospital 2008 –2014
Member, INOVA Heart/Lung Transplant Collaborative Practice Committee 1998 – 2014
President, Chairman, INOVA Fairfax Medical Staff, Medical Executive Committee 2011 – 2013
Member, Command Center Committee for Disaster and Bioterrorism Events, INOVA Fairfax Hospital 2011 – 2013
Chair, Medical Quality Improvement Committee, INOVA Fairfax Hospital 2010
Vice President, Medical Executive Committee, INOVA Fairfax Hospital 2010
Secretary/Treasurer, Medical Executive Committee, INOVA Fairfax Hospital 2008 – 2010
Member-at-Large, Medical Executive Committee, INOVA Fairfax Hospital 2004 – 2007
Member, INOVA Managed Care Advisory Council 1998 – 2002
Member, INOVA Institutional Review Board 1998 – 2001
Member, INOVA Outpatient Pediatric Collaborative Committee 1994 – 1997
Member, Future Planning Program and Round Table Discussions, INOVA Fairfax Hospital 1993 – 1994

PROFESSIONAL ORGANIZATIONS

Member, American Medical Association
Fellow, American College of Physicians
Member, Greater Washington Infectious Disease Society
Medical Society of Virginia
Northern Virginia Representative, Health Care Financing and Policy Task Force (2003 – Present)
Chairperson, Hospital Bi-Laws Task Force (2007)

Director/Board Member (2000 – 2006)
Member, Legislative Committee (1996 – 2005)
Chairman, Medical Economic Committee (2000 – 2002)
1996 – Present
Infectious Diseases Society of America
Fellow Member, Outpatient Antibiotic Therapy Committee 2003 – 2006
Member, Clinical Affairs Committee 2000 – 2003
Medical Society of Northern Virginia/Fairfax County Medical Society
President (2003)
President Elect (2002)
Vice President (2001)
Secretary (2000)
Treasurer (1999)
Chairman, Legislative/Managed Care Committee (1996 – 2003)
1996 – 2003

TEACHING APPOINTMENTS

Department of Medicine, INOVA Fairfax Medical Campus 2015 – Present
Infectious Disease Physicians, Inc.

  • National Institute of Health Infectious Disease Fellows outpatient infectious diseases training
2009 – 2014
George Washington University Hospital
Director, Program Developer

  • Transplant Infectious Disease rotation for fellows in Infectious Diseases
2005 – 2014
Virginia Commonwealth University
Director of Curriculum Development

  • Medical Student Infectious Disease elective at INOVA Fairfax Hospital
2003 – 2010
INOVA Fairfax Hospital
Professor

  • Microbiology Lecture on Infectious Diseases for the Medical Technologists in training (2000 – 2009)
  • Provide Infectious Diseases clinical training for the INOVA Fairfax Hospital Podiatry Residents (2002 – 2008)
2000 – 2009
Georgetown University Medical School

  • Physical Diagnosis course for second-year Medical Students
2002 – 2008

HOSPITAL AFFILIATIONS

INOVA Fairfax Hospital, Falls Church, VA 1992 – Present
INOVA Fair Oaks Hospital, Fairfax, VA 1992 – 2008
Reston Hospital Center, Reston, VA 1996 – 2002

BOARD CERTIFICATIONS

Diplomat, National Board of Medical Examiners 1985 – Present
Diplomat, American Board of Internal Medicine, Internal Medicine 1988 – Present
Diplomat, American Board of Internal Medicine
Infectious Diseases, Recertified, 2002, 2013
1992 – Present
Diplomat, American Board of Pediatrics 1989, 2002

HONORS & AWARDS

Best Doctor’s in Virginia 2011 – 2015
Top Doctor’s in America 2007 – 2015
Top Doctor’s, Washingtonian Magazine 1999 – 2015
Super Doctor’s, Washington, D.C. 2011 – 2014
Best Physician’s, Washington Consumer Checkbook 1999 – 2014
Vernon K. Vance Memorial Award for Teaching Excellence, INOVA Fairfax Hospital 2003
Alumni Fellow of the Year Fellow, Elizabethtown College 1993

INVESTIGATIONS (Past to Present)

Site Investigator, NIAID HIV in Women’s Study, WISE study, INOVA-HIV Services, 1994 – 1996

Site Investigator, INOVA Fairfax Hospital, Synercid Compassionate Use. Rhone-Poulenc-Rorer, 1994 – 1996

Site Investigator, INOVA Fairfax Hospital, Amphotericin-B, Lipid Complex (compassionate use) Lissome Company, 1994 – 1996

Sub Investigator, Evaluation of Nevirapine in HIV Positive Individuals (HVP1038A), 1994

Sub-Investigator, Evaluation of GM-CSF in Neutropenic HIV Positive Individuals, 1994

Co-Investigator, Chronic Fatigue Syndrome Behavior Modification, Dept. of Psychiatry, INOVA Fairfax Hospital, 1995

Sub-Investigator, 3TC Open-label Protocol NUCU-3004.  Evaluation of 3TC in Symptomatic HIV-Diseased Population Who is Unable to Participate in All Other Approved Therapies, 1995

Sub-Investigator, Open-label Safety Study of Oral Gancyclovir Maintenance Treatment of CMV Retinitis in People with Limited Venous Access (GANS2224), 1995

Sub-Investigator, Open-Label Multicenter Study to Provide Expanded Access and to Obtain Additional Safety Data on Serostim (mammalian cell-derived recombinant human growth hormone) r-hGM [m] in the Treatment of Adults with AIDS Wasting (Particularly. 7623), 1995

Sub-Investigator, A Phase III Safety and Efficacy Trial of ABT-538 plus Current Therapy vs. Placebo plus Current Therapy in HIV-Infected Patients (M94-247). 1995

Site Investigator, Viracept Expanded Access Program (Protocol AG1343-515). 1997

Sub-Investigator Synercid for Complicated Vancomycin-resistant Enterococcal Infection, Rhone-Poulenc Protocol JRV-398. 1997

Site Investigator, A random open label multi-crossover study to observe subject preference for two package forms of Mepron Suspension (ATO-R07). 1998

Sub-Investigator, Sustiva Expanded Access Program (Protocol DMP 266-903). 1998

Site Investigator, A 1592U89 Open Label Protocol for Adult Patients with HIV-1 Infection- Part B (Protocol CNAA3008). 1998

Principal Investigator, The Effect of a Weekly Dosing Regimen of Procrit (Epoetin alfa) on the Quality of Life in the Treatment of Anemia in HIV-Infected Patients on Anti-retroviral Therapy (Protocol PR98-29-002). 1998

Investigator, MultiCenter, Double Blind, Placebo Controlled Trial of Pleconaril in the Treatment of Enteroviral Menigitis in Children and Adolescents (Protocol #843-019), in Adolescents and Adults, (protocol #843-018) ViroPharma Inc. 1998

Sub-Investigator, Abbott Protocol M99-046, ABT-378/r Compassionate Use in HIV treatment. 1998
Sub-Investigator Ziagen Phase IV Zorro Study, Glaxo-Welcome Protocol ESS40009. 2000

Principal Investigator, A Prospective Open-label Study to Access the Efficacy and Safety of Higher Daily Dosing of Amphotericin B Lipid Complex in Patients with Serious Fungal Infections, Lipsome Company, Inc. 2000

Principal Investigator, Utility of CMV PCR in the Management of Solid Organ Transplant Recipients. INOVA Fairfax Hospital. 2000

Sub-Investigator, A Phase V Multicenter Study of the Efficacy and Safety of 48-Week Induction with TRIZIVIR (Abacavir 300 mg/Lamivudine 150mg/Zidovudine 300mg Combination Tablet BID) + Efavirenz (600mg QD). Followed by 48-Week Randomized, Open-Label, Maintenance Treatment Naïve Subjects. 2001

Principal Investigator, Ortho-Biotech PR99-30-033. Co-infection Hepatitis C and HIV, anemia during therapy with Interferon and Ribavarin. 2002

Principal Investigator, Micafungin Protocol 03-0-192- “A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients with Invasive Candidiasis and Candidemia” Astellas Pharmaceuticals. 2004 – 2006

Sub-Investigator, Compassionate Use Tipranovir in the HIV Positive Patient. 2005

Sub-Investigator, A Study Comparing Safety of Abacavir and Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study). 2005

Infection rates, Lung transplantation patients, INOVA Fairfax Hospital. 2010 – 2012

Ventricular Assist Device Infections, types and rates, INOVA Fairfax Hospital. 2010 – 2014
Decubitis ulcer monitoring, INOVA Fairfax Hospital. ABIM, MOC 2013

Investigator, “A phase IV, randomized, investigator-blinded, single center clinical study to evaluate the safety, immunogenicity and efficacy of commercially available influenza trivalent inactive vaccine (TIV), single intramuscular dose of either Fluzone or Fluzone High-Dose after thirty days following solid organ transplantation (kidney, heart, and lung transplants).” 2013 – 2014

Principle Investigator, Schintler, Schmidt, Nicogossian. “Spatio-Temporal Analysis of Influenza in the INOVA Health System Region” a collaborative study with George Mason University. Transcript completed. 2013 – 2014

Gilman R, Schmidt M, Marcus R. Prevalence and Characteristics of Chagas Disease in Latino Patients in Fairfax County, VA.  Study Active, data actively being analyzed, John’s Hopkins School of Public Health. 2015 – Present

Djurkovic S, Elfeky S, Schmidt M, Golabi P, Younossi Z. Evaluation of sepsis data set parameters, INOVA Dept. of Medicine.   2016 – 2017

Evaluation of Diabetics use of a phone App to improve diabetes outcomes.  Impact of the One Drop Glucose Management System on Anti-Diabetic Medication Persistence and Adherence: A Prospective Observational Study. ICPH and IFMC. 2017 – 2019

MEDICAL SYMPOSIUM SPEAKING ENGAGEMENTS (Past to Present)

Clostridium difficile: Basic High Tech; The Infection Control Continuum. Fairfax, VA. 1993

Infectious Diseases During Pregnancy: Identification and Management. Washington, DC. 1993

HIV in Women: 5th Annual State-of-the-Art Approaches to Managing HIV in Women and Children. Northern Virginia Association of Pediatric Nurses. 1996

Tick-borne Diseases. Vencor Hospital Spring Symposium. Arlington, VA. 1997

The Changing Face of Infections in the Transplant Recipient, United Network for Organ Sharing Symposium, Bethesda, MD. 2002

Thoracic Transplantation Symposium, Infections in Transplant Recipients, INOVA Fairfax Hospital. 2003

Infectious Disease Society of America, Annual Meeting. Speaker, Advanced Coding and Contract Negotiations with Managed Care Companies; Moderator, Controversies in Clinical Infectious Disease-part II. 2003

Infectious Disease Society of America, Annual Meeting. Outpatient Parenteral Antimicrobial Therapy Workshop, Speaker, Coding 101 and a Meet-the-Professor, Speaker, Billing for Everything. 2004

Infectious Disease Society of America Annual Meeting, Workshop Speaker, Outpatient Parenteral Antibiotic Therapy workshop, Topic; How to Negotiate. 2005

Moderator and Symposium planner, 2005 OPAT Workshop, Infectious Disease Society of America Annual Meeting. 2005

Infectious Disease Society of America Annual Meeting, Meet the Professor, Outpatient Antibiotics Update. 2006

Changing Bugs, New Drugs.  Internal Medicine Update and Symposium, INOVA Fairfax Hospital. 2006

Scientific Chair and Moderator, Medical Society of Virginia Annual Educational Symposium, “Quality Improvement Across the Commonwealth.” 2007

Methicillin-Resistant Staph aureus Update. Focus on Women’s Health Issues. OB/GYN and Internal Medicine, INOVA Fairfax Hospital. 2008

Speaker, Infectious Disease Update, Transplant Symposium, INOVA Fairfax Hospital. 2010

Speaker, Infectious Disease Update, Transplant Symposium, INOVA Fairfax Hospital. 2011

Speaker, Infectious Disease Update, Transplant Symposium, INOVA Fairfax Hospital. 2013

Dupont Summit 2014 on Science, Technology, and Environmental Policy Issues.  Disasters and Health Policy: Focus on Ebola Policies and Practices to Reduce Exposures and Infection Transmissions. 2014

MEDICAL MEETING SPEAKING ENGAGEMENTS (Past to Present)

New Extended Spectrum Antibiotics, INOVA Fairfax Hospital. 1992
Antibiotics: What’s New, Pediatric Infectious Diseases: “Hot-Cold” issues. INOVA Fairfax Hospital. 1994

Infections in Bone and Joints. Fairfax Hospital Orthopedic Surgery Resident Series. 1997 – 1999

Clinical Manifestations/ HIV Infection in Women. OB-GYN Grand Rounds, INOVA Fairfax Hospital. 1997

HIV in Women and Children. INOVA HIV Services. 1998

Infectious Diseases Update. Pediatric Grand Rounds. INOVA Fair Oaks Hospital. 1998

Smith-Kline Speakers Series, Lymerix Vaccine. 1998

Update, Treatment in Fungal Infections. Grand Rounds, Montgomery General Hospital, Maryland. 2003

Treatment of Fungal Infection in the Bone Marrow Transplant Recipient, INOVA Bone Marrow Transplantation Team. 2003

Pfizer Speaker Series, VFEND (Voriconazole) for Fungal Infections. 2002 – 2003
Cubist, Daptomycin Speaker Series. 2004 – 2010

Grand Rounds Speaker, Mt. Vernon Hospital, Infectious Disease Update, “Old Bugs, New Tricks.” 2007

Grand Rounds Speaker, Dept. OB/Gyn INOVA Fairfax Hospital, Vaccine Update. 2007

Sanofi-Pasteur Vaccine Speaker. 2007

PUBLIC SYMPOSIUM

Technology Cost Driver Symposium “Technology’s impact on the Market,” National Press Club, Washington, DC. 2001

SCIENTIFIC PAPERS

Schmidt ME, Aliso B, Parenti D, Elgart M, Williams CM.  Rapidly Progressive Penile Ulcer: An Unusual Presentation of Kaposi’s Sarcoma of the Penis. American Academy of Dermatology 1992; 27(2):267-8.

Schmidt ME, Smith MA, Levy, CS.  Endopthalmitis Caused by Unusual Gram-Negative Bacilli. Clinic Infectious Diseases 1993; (17):686-90.

Schmidt ME, Gilbert CL, Gordin FM. Clostridium difficile Colitis Association with Trimethoprim-Sulfamethoxazole Given as Prophylaxis for Pneumocystis carinii Pneumonia. American Journal of Medicine 1994; (1):94-5.

Schmidt ME. HIV Update. Antibiotics, Questions and Quandaries. VA Medical Quarterly 1997, 124(2):105-107.

Nathan SD, Shorr AF, Schmidt ME, Burton NA. Aspergillus and Endobronchial Abnormalities in Lung Transplant Recipients. Chest 2000: 118 (2): 403-407.

Petrak RM, Sexton DJ, Butera ML, Tenenbaum MJ, MacGregor MC, Schmidt ME, Joseph WP, Kemmerly SA, Dougherty MJ, Bakken JS, Curfman MF, Martineli LP,
Gainer RB. The Value of an Infectious Disease Specialist. Clinical Infectious Diseases 2003; (36): 1013-1017.

Elizabeth B. Gray, Theresa Benedict, Hilda Rivera, Shirish Huprikar, Phillip C. Zakowski, Bernard Kubak, Marcus R. Pereira, Abhay Dhand, Evan P. Kransdorf, Edward Stenehjem, Mary Schmidt, S. halika Katugaha, Lisa Stocks, Kristin W. Delli Carpini, Joselina R. Fuentes, Loretta S. Kiros, Susan Montgomery.  Trypanosoma cruzi Infections in Solid Organ Transplant Recipients. Open Forum Infectious Diseases, Volume 2, Issue suppl.  Published: 09 December 2015.  https://doi.org/10.1093/ofid/ofv131.54

Elfeky S, Golabi P, Otgonsuren M, Djurkovic S, Schmidt ME, Younossi ZM.  The epidemiologic characteristics, temporal trends, predictors of death, and discharge disposition in patients with a diagnosis of sepsis: A cross-sectional retrospective cohort study. Crit Care. 2017 Jun; 39:48-55. doi: 10.1016/j.jcrc.2017.01.006. Epub 2017 Jan 20.

Mary E. Schmidt, Michael E. von Fricken, Rachel N. Wofford, Russel C. Libby, P. J. Maddox. Access to Care During a Pandemic: Improving Planning Efforts to Incorporate Community Primary Care Practices and Public Health Stakeholders. World Medical & Health Policy; 2020. Accepted for Publication.

ABSTRACTS

S. Villazon, MD, F.N.Pierce, MD , S.D.Nathan, MD , O.A.Shlobin, MD, S.D.Barnett, PhD, E.A.Lefrak, MD, M.E.Schmidt, MD, N.Burton, MD, and S.Ahmad. Cytomegalovirus Prophylaxis for Lung Transplant Recipients: Comparison of Oral Valganciclovir to IV and Oral Ganciclovir., MD. Advanced Lung Disease and Transplant Program, INOVA Fairfax Hospital, Falls Church, VA. Presented at ATS International Conference, May 2008

S.Ahmad, MD, O.A.Shlobin, MD, S.D.Barnett, PhD, E.A.Lefrak, MD, M.E.Schmidt, MD, N.Burton, MD, and  S.D.Nathan, Cytomegaloviral Shedding in Bronchoalveolar Lavage in Lung Transplant Recipients: Comparison of Oral Valganciclovir to IV and Oral Ganciclovir based Prophylactic Regimens. MD. Presented at ATS international conference May 2009

Staph Infections: Health Story. Gray EB, Benedict T, BS, Rivera H, Huprikar S, Zakowski PC, Pereira MR,  Kransdorf EP, Stenehjem E, Schmidt M, Katugaha S, Stocks L, Delli-Carpini K,  Montgomery S. Trypanosoma cruzi Infections in Solid Organ Transplant Recipients, 2014. Presented at ID Week, October 2015.

CURRENT COMMUNITY CONTRIBUTIONS

Board Member, Families Against Cult Teachings

Friends of Music and Theater, George Mason University, College of Visual and Performing Arts (Prior Board Member)

Board Member Project Access, free specialty medical care program in Fairfax County & Alexandria County, VA

Volunteer and Support, Community Coalition to Haiti

Dr. Mary E. Schmidt-Libby Scholarship, Elizabethtown College, Dept of Biology
Frank Polanowski Award for Mentorship, Elizabethtown College

Leona Libby Feldman Scholarship, George Washington University, School of Medicine